Evaluating the clinical impact of the 2023 FIGO staging for endometrial cancer: Complexities and considerations

Lobna Ouldamer1, Martin Koskas2, Xavier Carcopino3

  • 1Department of Gynecology. CHRU de Tours, Hôpital Bretonneau, 2 boulevard Tonnellé, 37044 Tours, France; François Rabelais University, Tours, France; INSERM Unit 1069, Tours, France.

Abstract

No abstract available in PubMed .

Related Concept Videos